跳至主要内容
临床试验/NCT06368505
NCT06368505Unknown不适用

A Prospective Comparative Study on the Efficacy of Ultrasound-Guided Platelet-Rich Plasma Injection Versus Hydrodissection in the Treatment of Carpal Tunnel Syndrome

Osama Ahmed Elshafei1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2024年1月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
64
试验地点
1
主要终点
The visual analog scale (VAS)

研究概览

简要总结

The goal of this clinical trial is to compare the efficacy of Ultrasound-Guided Platelet-Rich Plasma Injection versus Hydrodissection (using 2ml saline, 2ml dexamethasone and 1ml lidocaine) in the Treatment of Carpal Tunnel Syndrome. The main questions it aims to answer are:

  • Which modality is more effective in reducing symptoms and improving function in patients with Carpal tunnel syndrome
  • Asses safety profile of both methods

Participants will:

  • Randomized to one of the two arms
  • Visit the clinic 1 and 3 months after intervention
  • Assessed for efficacy and safety of the intervention

详细描述

The medical records of patients diagnosed with carpal tunnel syndrome will be reviewed using a computerized carpal tunnel syndrome sheet including all variables for each patient assessing the symptoms and the functional condition by assessing changes in the usual daily routines. The assessment of the patients was done before and after the intervention (1 and 3 months later).

The CSA is obtained (in mm² at distal wrist crease) using ultrasound. Then the CTS grading was determined via US staging 9-13, 13-15, >15 as mild, moderate and severe respectively.

Ultrasound-Guided Intracarpal Injection. High-resolution US examination will be done by using a GE Logiq E9 with ML6-15-D Matrix linear array probe (USA). Under sterile conditions, a 25-gauge needle will be used using ulnar approach and under real time visualization the needle will be guided to the superficial ulnar aspect of the median nerve. The patients will be randomized into two groups

PRP group:

whole blood is initially collected in tubes that contain anticoagulants, such as citrate dextrose A to prevent platelet activation prior to its use. Then PRP is prepared by a differential centrifugation. Then 3ml of PRP will be delivered via the in-plane ulnar approach

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients diagnosed clinically as carpal tunnel syndrome with at least 3 months of symptoms and confirmed electro-physiologically as carpal tunnel syndrome

排除标准

  • •Onset of carpal tunnel syndrome during pregnancy
  • •Co-existence of brachial plexopathy or thoracic outlet syndrome by clinical examination
  • •Previous carpal tunnel decompressive surgery or corticosteroid injection in carpal tunnel
  • •Patients with infection or local edema at the site of injection.

研究组 & 干预措施

Platelet rich plasma

Experimental

3 ml PRP injection

干预措施: ultrasound guided PRP injection (Other)

hydrodissection

Experimental

5ml injectate

干预措施: ultrasound guided hydrodissection (Other)

结局指标

主要结局

The visual analog scale (VAS)

时间窗: before the intervention,1 and 3 months after intervention

The Visual Analogue Scale (VAS) is a simple assessment tool used to measure pain intensity. The VAS consists of a straight horizontal line, usually 10 centimetres (cm) in length. One end of the line represents "no pain," while the other end represents "the worst pain ever experienced." Patients are asked to rate their current level of pain by placing a mark on the line. Using a ruler, the score is determined by measuring the distance (in millimetres) from the "no pain" anchor to the patient's mark. The resulting score ranges from 0 to 100, with a higher score indicating greater pain intensity.

Boston Carpal Tunnel Syndrome Questionnaire (BCTQ)

时间窗: before the intervention,1 and 3 months after intervention

Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) is a patient-based questionnaire, consists of two main scales: Symptom Severity Scale (SSS): Measures the severity of symptoms related to CTS. Functional Status Scale (FSS): Assesses functional limitations caused by CTS. Each scale contains several items, and patients rate their symptoms or functional difficulties on a scale from 1 to 5. A score of 1 indicates no symptoms or functional difficulty. A score of 5 represents maximum symptoms or inability to perform the task1. Interpretation: Higher scores on both scales indicate worse symptoms or greater functional impairment due to CTS.

次要结局

  • The cross-sectional area (CSA) of the Median nerve(before the intervention and 3 months after intervention)

研究者

发起方
Osama Ahmed Elshafei
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Osama Ahmed Elshafei

lecturer of neurology

Mansoura University

研究点 (1)

Loading locations...

相似试验